Navigation Links
Life span of ovarian grafts longer than expected

Transplanting previously frozen ovarian tissue back into female cancer survivors can lead to long-term hormonal function and preservation of fertility, according to a new study by Samuel Kim from the University of Kansas Medical Center in the US. His work, which shows that hormonal function was restored in five women 12-20 weeks after transplantation, and in one case lasted for more than seven years, appears online in the Journal of Assisted Reproduction and Genetics, published by Springer.

Many female cancer patients want to remain fertile, and choose to freeze some of their ovarian tissue prior to cancer treatment. Following treatment, the frozen tissue is thawed and transplanted back into the survivor's body, in a different location - known as a 'heterotopic site'. However, the longevity of grafted ovarian tissue has been debated for many years, and it is still uncertain how long hormonal (endocrine) function of frozen-thawed ovarian tissue can be maintained.

Kim studied five cancer survivors who had undergone heterotopic ovarian transplantation between 2001-2011. Their frozen ovaries were rapidly thawed and transplanted into the abdominal region. Kim measured both the levels and function of the reproductive hormones in these women via monthly blood tests and ultrasounds after hormonal activity was confirmed. The women were monitored until cessation of hormonal function.

He found that hormonal function was restored in all five patients 12-20 weeks after transplantation. Long-term follow-up in four patients showed that these women needed a second transplantation within two years of the first. Interestingly, restoration of ovarian function after the second transplantation was faster and lasted longer, between nine months and seven years.

The longest duration of hormonal function was seen in a 28-year-old women who underwent ovarian transplantation in 2003 and 2004 after radiotherapy for cervical cancer. Even seven years after transplantation, the grafts were still producing hormones.

Kim concludes: "Re-establishment of long-term endocrine function after ovarian transplantation will benefit young cancer survivors with premature ovarian failure. To my knowledge, this is the longest duration of ovarian function reported in the literature after heterotopic transplantation of frozen-thawed human ovarian tissue."


Contact: Joan Robinson

Related biology news :

1. Researchers identify genes that may help in ovarian cancer diagnosis and prognosis
2. Longer sleep times may counteract genetic factors related to weight gain
3. Pain relief with PAP injections may last 100 times longer than a traditional acupuncture treatment
4. Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows
5. Study suggests why some animals live longer
6. The millennium-old olive trees of the Iberian Peninsula are younger than expected
7. Unexpected discovery reveals a new mechanism for how the cerebellum extracts signal from noise
8. Unexpected crustacean diversity discovered in northern freshwater ecosystems
Post Your Comments:
(Date:6/21/2016)... Columbia , June 21, 2016 ... to the new role of principal product architect ... named the director of customer development. Both will ... chief technical officer. The moves reflect NuData,s strategic ... in response to high customer demand and customer ...
(Date:6/9/2016)... 9, 2016  Perkotek an innovation leader in attendance control systems is proud to ... hours, for employers to make sure the right employees are actually signing in, and ... ... ... ...
(Date:6/2/2016)... -- The Department of Transport Management (DOTM) of ... US Dollar project, for the , Supply and ... and IT Infrastructure , to Decatur ... of Identity Management Solutions. Numerous renowned international vendors participated in ... was selected for the most compliant and innovative solution. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology: